Advertisement

What are IL-17 inhibitors?

Donna Hill Howes, RN
Family Practitioner

The drugs secukinumab (Cosentyx) and ixekizumab (Taltz) block certain immune system proteins (IL-17A) that can cause inflammation and psoriasis symptoms. They are approved for people with moderate-to-severe plaque psoriasis. They are given as injections, 1 or more weeks apart. The shots can be given by a doctor or people can give them to themselves.

This answer was adapted from Sharecare's award-winning AskMD app. Start a consultation now to find out what's causing your symptoms, learn how to manage a condition, or find a doctor.

Continue Learning about Plaque Psoriasis

Why Psoriasis is More Than a Skin Disorder
Why Psoriasis is More Than a Skin Disorder
Psoriasis is a chronic inflammatory skin disorder that affects millions of people worldwide. The most recognizable form is plaque psoriasis, which man...
Read More
What should I know before taking apremilast?
Donna Hill Howes, RNDonna Hill Howes, RN
If you have had a depressive disorder, apremilast may not be a good option for you. If you have sev...
More Answers
6 Psoriasis Self-Care Tips You Should Try
6 Psoriasis Self-Care Tips You Should Try6 Psoriasis Self-Care Tips You Should Try6 Psoriasis Self-Care Tips You Should Try6 Psoriasis Self-Care Tips You Should Try
Find out how you can manage your psoriasis on a daily basis.
Start Slideshow
How Often Should I See My Doctor About My Psoriasis?
How Often Should I See My Doctor About My Psoriasis?

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.